160 related articles for article (PubMed ID: 35110551)
1. A scoring system for predicting hepatocellular carcinoma risk in alcoholic cirrhosis.
Lee K; Choi GH; Jang ES; Jeong SH; Kim JW
Sci Rep; 2022 Feb; 12(1):1717. PubMed ID: 35110551
[TBL] [Abstract][Full Text] [Related]
2. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.
Ganne-Carrié N; Chaffaut C; Bourcier V; Archambeaud I; Perarnau JM; Oberti F; Roulot D; Moreno C; Louvet A; Dao T; Moirand R; Goria O; Nguyen-Khac E; Carbonell N; Antonini T; Pol S; de Ledinghen V; Ozenne V; Henrion J; Péron JM; Tran A; Perlemuter G; Amiot X; Zarski JP; Beaugrand M; Chevret S;
J Hepatol; 2018 Dec; 69(6):1274-1283. PubMed ID: 30092234
[TBL] [Abstract][Full Text] [Related]
3. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
4. A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.
El-Serag HB; Kanwal F; Davila JA; Kramer J; Richardson P
Gastroenterology; 2014 May; 146(5):1249-55.e1. PubMed ID: 24462733
[TBL] [Abstract][Full Text] [Related]
5. Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification.
Ioannou GN; Green P; Kerr KF; Berry K
J Hepatol; 2019 Sep; 71(3):523-533. PubMed ID: 31145929
[TBL] [Abstract][Full Text] [Related]
6. [Screening for hepatocarcinoma in a cohort with cirrhosis mainly of alcoholic origin].
Henrion J; Libon E; De Maeght S; Deltenre P; Schapira M; Ghilain JM; Maisin JM; Heller FR
Gastroenterol Clin Biol; 2003 May; 27(5):534-9. PubMed ID: 12843918
[TBL] [Abstract][Full Text] [Related]
7. Albumin-Bilirubin (ALBI) Grade-Based Nomogram for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
Ho SY; Hsu CY; Liu PH; Lee RC; Ko CC; Huang YH; Su CW; Hou MC; Huo TI
Dig Dis Sci; 2021 May; 66(5):1730-1738. PubMed ID: 32548811
[TBL] [Abstract][Full Text] [Related]
8. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
[TBL] [Abstract][Full Text] [Related]
9. No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients With Cirrhosis.
Moon AM; Weiss NS; Beste LA; Su F; Ho SB; Jin GY; Lowy E; Berry K; Ioannou GN
Gastroenterology; 2018 Oct; 155(4):1128-1139.e6. PubMed ID: 29981779
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic significance of estimation of serum apolipoprotein A along with alpha-fetoprotein in alcoholic cirrhosis and hepatocellular carcinoma patients.
Nayak SS; Kamath SS; Kundaje GN; Aroor AR
Clin Chim Acta; 1988 Apr; 173(2):157-64. PubMed ID: 2454172
[TBL] [Abstract][Full Text] [Related]
11. Esophageal varices are not predictive of patient prognosis after surgical resection of hepatocellular carcinoma.
Chang CY; Hsieh WY; Chau GY; Chen PH; Su CW; Hou MC; Lei HJ; Huo TI; Huang YH; Lin HC; Wu JC
Eur J Gastroenterol Hepatol; 2018 Nov; 30(11):1368-1377. PubMed ID: 29994873
[TBL] [Abstract][Full Text] [Related]
12. Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma.
Mazzaferro V; Sposito C; Zhou J; Pinna AD; De Carlis L; Fan J; Cescon M; Di Sandro S; Yi-Feng H; Lauterio A; Bongini M; Cucchetti A
Gastroenterology; 2018 Jan; 154(1):128-139. PubMed ID: 28989060
[TBL] [Abstract][Full Text] [Related]
13. Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma.
Kornberg A; Schernhammer M; Kornberg J; Friess H; Thrum K
Dig Dis Sci; 2019 Jan; 64(1):269-280. PubMed ID: 30259282
[TBL] [Abstract][Full Text] [Related]
14. A Patient-Based Nomogram for Predicting Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma.
Lee S; Han S; Shim JH; Kim SY; Won HJ; Shin YM; Kim PN; An J; Lee D; Kim KM; Lim YS; Chung YH; Lee YS; Lee HC
J Vasc Interv Radiol; 2015 Dec; 26(12):1787-94.e1. PubMed ID: 26542708
[TBL] [Abstract][Full Text] [Related]
15. Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: a Danish nationwide cohort study.
Jepsen P; Ott P; Andersen PK; Sørensen HT; Vilstrup H
Ann Intern Med; 2012 Jun; 156(12):841-7, W295. PubMed ID: 22711076
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of α-fetoprotein as a diagnostic tool for hepatocellular carcinoma in Korea.
Ahn DG; Kim HJ; Kang H; Lee HW; Bae SH; Lee JH; Paik YH; Lee JS
Korean J Intern Med; 2016 Jan; 31(1):46-53. PubMed ID: 26767857
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of HCC in Brazil: incidence and risk factors in a ten-year cohort.
Paranaguá-Vezozzo DC; Ono SK; Alvarado-Mora MV; Farias AQ; Cunha-Silva M; França JI; Alves VA; Sherman M; Carrilho FJ
Ann Hepatol; 2014; 13(4):386-93. PubMed ID: 24927609
[TBL] [Abstract][Full Text] [Related]
18. Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening.
Simão A; Madaleno J; Silva N; Rodrigues F; Caseiro P; Costa JN; Carvalho A
BMC Gastroenterol; 2015 Jun; 15():73. PubMed ID: 26122937
[TBL] [Abstract][Full Text] [Related]
19. Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.
Cho HJ; Kim B; Lee JD; Kang DR; Kim JK; Lee JH; Shin SJ; Lee KM; Yoo BM; Lee KJ; Kim SS; Cheong JY; Cho SW
Am J Gastroenterol; 2017 Mar; 112(3):460-470. PubMed ID: 27779194
[TBL] [Abstract][Full Text] [Related]
20. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
[Next] [New Search]
